A carregar...

The Role of Donor Lymphocyte Infusion (DLI) in Post Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era

Treatment for relapse of chronic myeloid leukemia (CML) following hematopoietic cell transplantation (HCT) includes tyrosine kinase inhibitors (TKI) with or without donor lymphocyte infusions (DLI), however the most effective treatment strategy is unknown. This study was performed through the Center...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Schmidt, Sarah, Liu, Ying, Hu, Zhen-Huan, Williams, Kirsten M., Lazarus, Hillard M., Vij, Ravi, Kharfan-Dabaja, Mohamed A., Ortí, Guillermo, Wiernik, Peter H., Weisdorf, Daniel, Kamble, Rammurti T., Herzig, Roger, Wirk, Baldeep, Cerny, Jan, Bacher, Ulrike, Chaudhri, Naeem A, Nathan, Sunita, Farhadfar, Nosha, Aljurf, Mahmoud, Gergis, Usama, Szer, Jeffrey, Seo, Sachiko, Hsu, Jack W., Olsson, Richard F., Maharaj, Dipnarine, George, Biju, Hildebrandt, Gerhard C., Agrawal, Vaibhav, Nishihori, Taiga, Abdel-Azim, Hisham, Alyea, Edwin, Popat, Uday, Sobecks, Ronald, Scott, Bart L., Chakrabarty, Jennifer Holter, Saber, Wael
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7367282/
https://ncbi.nlm.nih.gov/pubmed/32062061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.02.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!